New hope for stiff hearts: can a common pill reverse scarring?
NCT ID NCT06536309
Summary
This study aims to see if a medication called sacubitril/valsartan can reduce harmful scarring (fibrosis) inside the heart muscle of people with a specific type of heart failure. Researchers will compare it to another standard medication using heart MRI scans to measure changes in scarring over one year. The goal is to understand if this drug works by directly improving the heart's structure, which could help identify which patients benefit most.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.